mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |